ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.
常見問題
ProUroCare Medical 今天的股價是多少?▼
PUMD 目前價格為 $0.00 USD,過去 24 小時上漲了 +0%。在圖表上更密切關注 ProUroCare Medical 股價表現。
ProUroCare Medical 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 OTC Link 交易所,ProUroCare Medical 的股票以代號 PUMD 進行交易。
ProUroCare Medical 上一季度的財報如何?▼
PUMD 上一季度的財報為每股 -0.02 USD,預估為 不適用 USD,帶來 不適用 的驚喜。下一季度的預估財報為每股 不適用 USD。
ProUroCare Medical 有多少名員工?▼
截至 2026年11月1日,公司共有 2 名員工。
ProUroCare Medical 位於哪個產業?▼
ProUroCare Medical從事於Health & Wellness產業。
ProUroCare Medical 何時完成拆股?▼
ProUroCare Medical 最近沒有進行任何拆股。
ProUroCare Medical 的總部在哪裡?▼
ProUroCare Medical 的總部位於 美國 的 Eden Prairie。